版权说明 操作指南
首页 > 成果 > 详情

Postoperative Radiotherapy Involving Tumor Bed with or without Elective Nodal Irradiation in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: A Multi-Center, Prospective Randomized Phase II Trial

认领
导出
Link by DOI
反馈
分享
QQ微信 微博
成果类型:
期刊论文、会议论文
作者:
Zeng, Y.;Cai, X.;Li, J.;Ye, J.;Han, G.;...
通讯作者:
Y. Zeng
作者机构:
[Fu, X. L.; Cai, X.; Zeng, Y.] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Radiat Oncol, Shanghai, Peoples R China.
[Li, J.] Fujian Canc Hosp, Dept Radiat Oncol, Fuzhou, Peoples R China.
[Li, J.] Fujian Med Univ, Canc Hosp, Fuzhou, Peoples R China.
[Ye, J.] Nanjing Med Univ, Jiangsu Canc Hosp, Affiliated Canc Hosp, Nanjing, Peoples R China.
[Han, G.] Taizhou City Peoples Hosp, Zhenjiang, Jiangsu, Peoples R China.
通讯机构:
[Y. Zeng] D
Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China
语种:
英文
期刊:
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
ISSN:
0360-3016
年:
2022
卷:
114
期:
3, Supplement
页码:
S119-S119
会议名称:
Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO)
会议时间:
OCT 23-26, 2022
会议地点:
ELECTR NETWORK
出版地:
STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
出版者:
ELSEVIER SCIENCE INC
机构署名:
本校为其他机构
摘要:
Postoperative radiotherapy (PORT) is necessary in patients with locally advanced esophageal squamous cell carcinoma (LA-ESCC) who have not received neoadjuvant chemoradiotherapy (NCRT). However, the optimal clinical target volume has under hot debate for decades. This clinical trial aims to estimate the optimal radiation volume of PORT for patients with LA-ESCC. Patients confirmed LA-ESCC (pT3-4N0-3M0) after esophagectomy without NCRT were randomly assigned to either large-field irradiation (LFI, primary lesion and lymph node tumor bed plus ele...

反馈

验证码:
看不清楚,换一个
确定
取消

成果认领

标题:
用户 作者 通讯作者
请选择
请选择
确定
取消

提示

该栏目需要登录且有访问权限才可以访问

如果您有访问权限,请直接 登录访问

如果您没有访问权限,请联系管理员申请开通

管理员联系邮箱:yun@hnwdkj.com